Menard Financial Group LLC Pfizer Inc Transaction History

Menard Financial Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $177,020 - $231,080	4,240 New	4,240 $217,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $174,907 - $259,271	4,233 New	4,233 $250,000
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $431,638 - $488,973	-12,020 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $20,027 - $22,586	-598 Reduced 4.74%	12,020 $435,000
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $47,962 - $60,988	-1,433 Reduced 10.2%	12,618 $464,000
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $29,654 - $34,791	-934 Reduced 6.23%	14,051 $516,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $451,348 - $547,551	14,985 New	14,985 $490,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $485,756 - $694,040	-17,971 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $591,605 - $671,396	17,971 New	17,971 $704,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Menard Financial Group LLC with notifications on news.